Heterogeneous intracellular expression of B-cell receptor components in B-cell chronic lymphocytic leukaemia (B-CLL) cells and effects of CD79b gene transfer on surface immunoglobulin levels in a B-CLL-derived cell line

Sonia Minuzzo, Stefano Indraccolo, Valeria Tosello, Erich Piovan, Anna Cabrelle, Livio Trentin, Giampietro Semenzato, Alberto Amadori

Research output: Contribution to journalArticle

7 Citations (Scopus)

Abstract

B-cell chronic lymphocytic leukaemia (B-CLL) cells display low amounts of surface immunoglobulins (sIg). To investigate the mechanisms underlying this phenomenon, we performed a thorough study of surface and intracellular expression of the B-cell receptor (BCR) components in B-CLL cells using flow cytometry. There was an heterogeneous pattern of expression. Overall, 20 of 22 samples showed reduced sIgM levels, compared with normal B cells. Among them, three (15%) had very low to undetectable intracellular IgM levels and variable amounts of CD79a and CD79b; nine (45%) had low intracellular CD79b levels but appreciable levels of IgM and CD79a; and eight (40%) had relatively normal intracellular levels of all BCR components. To investigate whether surface BCR levels could be controlled by the rate of CD79b synthesis, adenoviral vectors encoding CD79b were generated and used for gene transfer experiments. Delivery of CD79b to non-B cells transfected with IgM and CD79a lead to high-level expression of a functional BCR. Moreover, CD79b gene transfer in a B cell line derived from a B-CLL patient and characterised by low intracellular levels of endogenous CD79b consistently increased sIgM levels. These findings indicate that the phenotype of B-CLL cells in a subset of patients may depend primarily on poor CD79b expression, and suggest that upregulation of CD79b expression may correct the phenotype of these cells.

Original languageEnglish
Pages (from-to)878-889
Number of pages12
JournalBritish Journal of Haematology
Volume130
Issue number6
DOIs
Publication statusPublished - Sep 2005

Fingerprint

B-Cell Antigen Receptors
B-Cell Chronic Lymphocytic Leukemia
Cellular Structures
B-Lymphocytes
Cell Line
Genes
Immunoglobulin M
Phenotype
Cell Surface Receptors
Flow Cytometry
Up-Regulation

Keywords

  • Adenoviral vector
  • B-cell receptor
  • CD79b
  • Chronic lymphocytic leukaemia
  • Gene transfer

ASJC Scopus subject areas

  • Hematology

Cite this

@article{5f310dca827c49f5a286ba2e0beecd3e,
title = "Heterogeneous intracellular expression of B-cell receptor components in B-cell chronic lymphocytic leukaemia (B-CLL) cells and effects of CD79b gene transfer on surface immunoglobulin levels in a B-CLL-derived cell line",
abstract = "B-cell chronic lymphocytic leukaemia (B-CLL) cells display low amounts of surface immunoglobulins (sIg). To investigate the mechanisms underlying this phenomenon, we performed a thorough study of surface and intracellular expression of the B-cell receptor (BCR) components in B-CLL cells using flow cytometry. There was an heterogeneous pattern of expression. Overall, 20 of 22 samples showed reduced sIgM levels, compared with normal B cells. Among them, three (15{\%}) had very low to undetectable intracellular IgM levels and variable amounts of CD79a and CD79b; nine (45{\%}) had low intracellular CD79b levels but appreciable levels of IgM and CD79a; and eight (40{\%}) had relatively normal intracellular levels of all BCR components. To investigate whether surface BCR levels could be controlled by the rate of CD79b synthesis, adenoviral vectors encoding CD79b were generated and used for gene transfer experiments. Delivery of CD79b to non-B cells transfected with IgM and CD79a lead to high-level expression of a functional BCR. Moreover, CD79b gene transfer in a B cell line derived from a B-CLL patient and characterised by low intracellular levels of endogenous CD79b consistently increased sIgM levels. These findings indicate that the phenotype of B-CLL cells in a subset of patients may depend primarily on poor CD79b expression, and suggest that upregulation of CD79b expression may correct the phenotype of these cells.",
keywords = "Adenoviral vector, B-cell receptor, CD79b, Chronic lymphocytic leukaemia, Gene transfer",
author = "Sonia Minuzzo and Stefano Indraccolo and Valeria Tosello and Erich Piovan and Anna Cabrelle and Livio Trentin and Giampietro Semenzato and Alberto Amadori",
year = "2005",
month = "9",
doi = "10.1111/j.1365-2141.2005.05699.x",
language = "English",
volume = "130",
pages = "878--889",
journal = "British Journal of Haematology",
issn = "0007-1048",
publisher = "John Wiley & Sons, Ltd (10.1111)",
number = "6",

}

TY - JOUR

T1 - Heterogeneous intracellular expression of B-cell receptor components in B-cell chronic lymphocytic leukaemia (B-CLL) cells and effects of CD79b gene transfer on surface immunoglobulin levels in a B-CLL-derived cell line

AU - Minuzzo, Sonia

AU - Indraccolo, Stefano

AU - Tosello, Valeria

AU - Piovan, Erich

AU - Cabrelle, Anna

AU - Trentin, Livio

AU - Semenzato, Giampietro

AU - Amadori, Alberto

PY - 2005/9

Y1 - 2005/9

N2 - B-cell chronic lymphocytic leukaemia (B-CLL) cells display low amounts of surface immunoglobulins (sIg). To investigate the mechanisms underlying this phenomenon, we performed a thorough study of surface and intracellular expression of the B-cell receptor (BCR) components in B-CLL cells using flow cytometry. There was an heterogeneous pattern of expression. Overall, 20 of 22 samples showed reduced sIgM levels, compared with normal B cells. Among them, three (15%) had very low to undetectable intracellular IgM levels and variable amounts of CD79a and CD79b; nine (45%) had low intracellular CD79b levels but appreciable levels of IgM and CD79a; and eight (40%) had relatively normal intracellular levels of all BCR components. To investigate whether surface BCR levels could be controlled by the rate of CD79b synthesis, adenoviral vectors encoding CD79b were generated and used for gene transfer experiments. Delivery of CD79b to non-B cells transfected with IgM and CD79a lead to high-level expression of a functional BCR. Moreover, CD79b gene transfer in a B cell line derived from a B-CLL patient and characterised by low intracellular levels of endogenous CD79b consistently increased sIgM levels. These findings indicate that the phenotype of B-CLL cells in a subset of patients may depend primarily on poor CD79b expression, and suggest that upregulation of CD79b expression may correct the phenotype of these cells.

AB - B-cell chronic lymphocytic leukaemia (B-CLL) cells display low amounts of surface immunoglobulins (sIg). To investigate the mechanisms underlying this phenomenon, we performed a thorough study of surface and intracellular expression of the B-cell receptor (BCR) components in B-CLL cells using flow cytometry. There was an heterogeneous pattern of expression. Overall, 20 of 22 samples showed reduced sIgM levels, compared with normal B cells. Among them, three (15%) had very low to undetectable intracellular IgM levels and variable amounts of CD79a and CD79b; nine (45%) had low intracellular CD79b levels but appreciable levels of IgM and CD79a; and eight (40%) had relatively normal intracellular levels of all BCR components. To investigate whether surface BCR levels could be controlled by the rate of CD79b synthesis, adenoviral vectors encoding CD79b were generated and used for gene transfer experiments. Delivery of CD79b to non-B cells transfected with IgM and CD79a lead to high-level expression of a functional BCR. Moreover, CD79b gene transfer in a B cell line derived from a B-CLL patient and characterised by low intracellular levels of endogenous CD79b consistently increased sIgM levels. These findings indicate that the phenotype of B-CLL cells in a subset of patients may depend primarily on poor CD79b expression, and suggest that upregulation of CD79b expression may correct the phenotype of these cells.

KW - Adenoviral vector

KW - B-cell receptor

KW - CD79b

KW - Chronic lymphocytic leukaemia

KW - Gene transfer

UR - http://www.scopus.com/inward/record.url?scp=27244433608&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=27244433608&partnerID=8YFLogxK

U2 - 10.1111/j.1365-2141.2005.05699.x

DO - 10.1111/j.1365-2141.2005.05699.x

M3 - Article

VL - 130

SP - 878

EP - 889

JO - British Journal of Haematology

JF - British Journal of Haematology

SN - 0007-1048

IS - 6

ER -